Literature DB >> 2813449

Interactions between bile and pancreatic juice diversions on cholecystokinin release and pancreas in conscious rats.

R Nakamura1, K Miyasaka, A Funakoshi, K Kitani.   

Abstract

Pancreatic exocrine secretion in the conscious rat is regulated by proteases secreted by the pancreas, and cholecystokinin (CCK) is known to be involved in its mechanism. It has also been reported that the absence of either pancreatic juice or bile in the duodenum could stimulate pancreatic secretion. Therefore, differences in CCK release responding to the exclusion of bile, pancreatic juice (PJ), or both bile and pancreatic juice (BPJ) from the intestine were examined by using a bioassay for cholecystokinin. Plasma CCK levels were increased by all three treatments compared with the basal value, the order of their effects being BPJ greater than PJ greater than bile diversion, and CCK concentrations produced by BPJ diversion were much greater than can be explained as simply summed effect of exclusions of bile and PJ. Pancreatic exocrine secretions were significantly increased by PJ and BPJ diversions, but the effect of bile diversion on the pancreas was not statistically significant. An additional infusion of CR-1409 (0.1 mg/rat), one of CCK receptor antagonists, inhibited exocrine function stimulated by BPJ diversion. We conclude (i) BPJ diversion is the strongest endogenous stimulant on CCK release; (ii) the potentiation between bile and PJ diversions is induced on CCK release; (iii) pancreatic protein secretion during BPJ diversion is mainly modulated by CCK.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2813449     DOI: 10.3181/00379727-192-42976

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  11 in total

1.  Prolonged stimulation of pancreatic serous secretions by bile and sodium taurocholate in anaesthetized rats.

Authors:  James D Morrison
Journal:  J Physiol Biochem       Date:  2012-04-27       Impact factor: 4.158

2.  Isolation and bioactivity of putative cholecystokinin-releasing peptide from rat small intestinal mucosa.

Authors:  K Miyasaka; A Funakoshi
Journal:  Gastroenterol Jpn       Date:  1992-02

3.  Somatostatin attenuates microcirculatory impairment in acute sodium taurocholate-induced pancreatitis.

Authors:  T Plusczyk; D Rathgeb; S Westermann; G Feifel
Journal:  Dig Dis Sci       Date:  1998-03       Impact factor: 3.199

Review 4.  Bile and pancreatic juice exclusion activates acinar stress kinases and exacerbates gallstone pancreatitis.

Authors:  Isaac Samuel
Journal:  Surgery       Date:  2007-12-21       Impact factor: 3.982

5.  Luminal bile regulates cholecystokinin release in conscious rats.

Authors:  R Nakamura; K Miyasaka; Y Kuyama; K Kitani
Journal:  Dig Dis Sci       Date:  1990-01       Impact factor: 3.199

6.  Regulation of intestinal concentration of cholecystokinin by bile and/or pancreatic juice.

Authors:  K Miyasaka; A Funakoshi; M Matsumoto; K Kitani
Journal:  Dig Dis Sci       Date:  1993-04       Impact factor: 3.199

7.  Direct, concentration-dependent inhibition by taurocholate of pancreatic exocrine secretion and CCK release in conscious rats.

Authors:  H Tomita; K Miyasaka; M Matsumoto; A Funakoshi
Journal:  Dig Dis Sci       Date:  1994-07       Impact factor: 3.199

8.  Effects of intraduodenal administration of a low dose of cholecystokinin (CCK) antagonist (CR-1505) on plasma CCK concentration, intestinal CCK content, and levels of CCK mRNA.

Authors:  N Sazaki; K Miyasaka; M Matsumoto; A Funakoshi
Journal:  J Gastroenterol       Date:  1995-10       Impact factor: 7.527

9.  Changes in plasma and duodenal cholecystokinin concentrations after pancreatic duct occlusion in rats.

Authors:  K Miyasaka; A Funakoshi; A Jimi; R Nakamura; M Matsumoto; K Kitani
Journal:  Dig Dis Sci       Date:  1992-03       Impact factor: 3.199

10.  Morphologic characterization of early ligation-induced acute pancreatitis in rats.

Authors:  David K Meyerholz; Isaac Samuel
Journal:  Am J Surg       Date:  2007-11       Impact factor: 2.565

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.